Skip to main content
. 2022 Jan 18;12:699535. doi: 10.3389/fphar.2021.699535

TABLE 2.

Pharmacokinetic data in rats. (A) Intravenous bolus administration for compound 7, 13, 14, and 15. (B) Oral administration for compound 7, 13, 14, 15 by gavage and food admix for compound 13. Abbreviations: AUC: area under the curve; CLp: plasma clearance; n: number of animals; FA: food admix; Oral F: oral bioavailability; T1/2: half-life; Tmax: time to maximal concentration; Vdss, volume of distribution.

A
Compound Dose (mg/kg) N CLp (ml/min/kg) Vdss (L/kg) T1/2 (h) AUC(0-inf) (hr*ng/mL)
14 3 2 47 0.9 1.3 1,070
13 2 3 1.6 0.3 2.6 21,000
7 3 2 23 1.3 0.8 2,140
15 3 2 156 1.7 0.35 321
B
Compound Dose (mg/kg) N Cmax (ng/ml) Tmax (h) AUC(0-inf) (hrs*ng/mL) T1/2 (h) Oral F (%)
14 30 3 130 0.5 660 3.8 6
13 10 2 17,690 0.75 130,000 4.6 80
13 (FA) 20 3 2,980 17 260,000 13 80
7 20 2 2,500 0.25 7,900 1.6 54
15 30 3 18 0.25 30 1.9 1.1

Bold values in this table are referring to the compound identifiers, which are kept in bold throughout the manuscript.